Phase 3 randomized, modified double-blind, active-controlled safety study on vYF in adults

Trial Identifier: VYF00019
Sponsor: Sanofi
Start Date: May 2025
Primary Completion Date: January 2026
Study Completion Date: January 2026
Condition: Yellow Fever Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
UNITED STATES, Georgia DECATUR, Georgia, UNITED STATES, 30030
UNITED STATES, Louisiana New Orleans, Louisiana, UNITED STATES, 70119
UNITED STATES, Maryland BALTIMORE, Maryland, UNITED STATES, 21205
UNITED STATES, Missouri St. Louis, Missouri, UNITED STATES, 63104
UNITED STATES, New York Rochester, New York, UNITED STATES, 14610
UNITED STATES, Rhode Island East Greenwich, Rhode Island, UNITED STATES, 02818
UNITED STATES, Utah Salt Lake City, Utah, UNITED STATES, 84109